UK pharma major GSK (LSE: GSK) today announced that, in connection with the mRNA patent settlement reached between CureVac ...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

Flutter Entertainment, which retains a London listing but is no longer part of the FTSE 100 index, fell 3% or 620p to 22,290p ...

The coming week sees the pace of corporate results reporting ease slightly, but still includes some big names, including insuers Aviva and Beazley; ...

GSK has proved to be a thoroughly disappointing addition to our income portfolio. Its share price has fallen by 9pc since our notional purchase in June last year, with the biopharmaceutical firm ...

Tan’s venture capital firm, based in San Francisco, has made significant investments in Chinese tech companies, including Semiconductor Manufacturing International Corp (SMIC), China's largest chip ...

US healthcare stocks struggle in 2025 due to government policies, sparking interest from bargain hunters as valuations reach ...

Key Points Dynavax Technologies (NASDAQ:DVAX) exceeded analyst expectations in Q2 2025, reporting GAAP revenue of $95.4 million and GAAP diluted EPS of $0.14. HEPLISAV-B, Dynavax's two-dose adult ...

Gilead Sciences, Inc.'s HIV dominance with Biktarvy & Yeztugo boosts revenue potential. Click for more about GILD and its ...

GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...